Gyre Therapeutics Inc. (GYRE NASDAQ) stock market data APIs
$7.949
0.26(3.3%)
as of February 3, 2026
Try our APIs with
free plan!
Gyre Therapeutics Inc. Financial Data Overview
Price chart is built with
Anychart
Gyre Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis. The company offers ETUARY (Pirfenidone), an anti-fibrotic drug approved for the treatment of idiopathic pulmonary fibrosis; and under Phase 3 trials for the treatment of pneumoconiosis. It is also involved in the development of F351 (Hydronidone), a structural derivative of ETUARY, under Phase 3 trials for the treatment of chronic hepatitis B (CHB)-associated liver fibrosis; and completed Phase 1 trials for the treatment of liver fibrosis associated with metabolic dysfunction-associated steatohepatitis. In addition, the company develops F573 is in Phase 2 clinical trials for the treatment of acute/acute-on-chronic liver failure. Further, its preclinical products include F230 for the treatment of pulmonary arterial hypertension; and F528 to treat chronic obstructive pulmonary disease. The company was founded in 2002 and is headquartered in San Diego, California. Gyre Therapeutics, Inc. operates as a subsidiary of GNI USA, Inc.
Prev. Close
7.949
Open
8.2094
High
8.2868
Low
7.6959
52 wk Range
6.11-13.75
Market Cap
763 M
P/E Ratio
198
Shares Outstanding
96 333 K
Revenue
107 M
EPS
0.03
Beta
7.048
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Gyre Therapeutics Inc. (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Gyre Therapeutics Inc. data using free add-ons & libraries
Get Gyre Therapeutics Inc. Fundamental Data
Gyre Therapeutics Inc. Fundamental data includes:
- Net Revenue: 107 M
- EBITDA: 14 359 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-07
- EPS/Forecast: 0.05
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Gyre Therapeutics Inc. News
New
Discovering Undiscovered Gems in the US Market
As the U.S. stock market navigates a week marked by tech earnings and geopolitical tensions, major indices like the Dow Jones, S&P 500, and Nasdaq have shown modest gains despite recent declines. Amid...
High Growth Tech Stocks To Watch In The US Market January 2026
As the U.S. market continues to reach new highs, with the S&P 500 and Dow Jones Industrial Average setting records despite concerns over a DOJ probe into Fed Chair Powell, investors are keeping a keen...
Undiscovered Gems in the US Market to Explore This December 2025
As the U.S. stock market continues to reach new heights, with the S&P 500 setting all-time records and major indices logging consecutive gains, investors are keenly observing the dynamics that drive t...
Exploring High Growth Tech Stocks in the US Market
The U.S. stock market recently experienced a significant downturn, with major indices such as the Nasdaq and S&P 500 closing sharply lower, driven by a notable decline in technology shares. In this en...
Get Gyre Therapeutics Inc. fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
